Search hospitals > Texas > Arlington

Texas Clinical Research Institute

Claim this profile
Arlington, Texas 76012
Global Leader in Non-alcoholic Fatty Liver Disease
Global Leader in Fatty Liver Disease
Conducts research for Hepatitis C
Conducts research for Liver Cirrhosis
Conducts research for Fibrosis
90 reported clinical trials
2 medical researchers
Photo of Texas Clinical Research Institute in ArlingtonPhoto of Texas Clinical Research Institute in ArlingtonPhoto of Texas Clinical Research Institute in Arlington

Summary

Texas Clinical Research Institute is a medical facility located in Arlington, Texas. This center is recognized for care of Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Hepatitis C, Liver Cirrhosis, Fibrosis and other specialties. Texas Clinical Research Institute is involved with conducting 90 clinical trials across 40 conditions. There are 2 research doctors associated with this hospital, such as Reem Ghalib, MD and M. Tarek Al-Assi, MD.

Area of expertise

1Non-alcoholic Fatty Liver Disease
Global Leader
Texas Clinical Research Institute has run 34 trials for Non-alcoholic Fatty Liver Disease. Some of their research focus areas include:
Stage I
Stage II
stage 2
2Fatty Liver Disease
Global Leader
Texas Clinical Research Institute has run 33 trials for Fatty Liver Disease. Some of their research focus areas include:
Stage I
Stage II
stage 2

Top PIs

Clinical Trials running at Texas Clinical Research Institute

Ulcerative Colitis
Non-alcoholic Fatty Liver Disease
Liver Cirrhosis
Ulcer
Inflammatory Bowel Disease
Type 2 Diabetes
Nonalcoholic Steatohepatitis
Fatty Liver Disease
Cholangitis
Primary Biliary Cirrhosis
Image of trial facility.

Etrasimod

for Ulcerative Colitis

This study is evaluating whether a drug may help treat ulcerative colitis.
Recruiting2 awards Phase 31 criteria
Image of trial facility.

ABX464 Maintenance Therapy

for Ulcerative Colitis

This is a multicenter, randomized study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies [corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)] and/or advanced therapies [biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors]. This study is the maintenance phase of both previous induction studies ABX464-105 and ABX464-106. All eligible subjects who have completed either one of the induction studies above mentioned, will be given the opportunity to take part in the present ABX464-107 maintenance study and will be randomized to either a double blind, placebo-controlled part (Part #1) or allocated to ABX464 50mg or 25mg open label treatment arms (Part #2) depending on their clinical response at the end of induction. This study consists of a 44-week treatment phase and a 28-days follow-up period consisting in the End of Study (EOS) visit.
Recruiting1 award Phase 3
Image of trial facility.

ABX464

for Ulcerative Colitis

This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies [corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)] and/or advanced therapies [biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors].
Recruiting1 award Phase 36 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Texas Clinical Research Institute?
Texas Clinical Research Institute is a medical facility located in Arlington, Texas. This center is recognized for care of Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Hepatitis C, Liver Cirrhosis, Fibrosis and other specialties. Texas Clinical Research Institute is involved with conducting 90 clinical trials across 40 conditions. There are 2 research doctors associated with this hospital, such as Reem Ghalib, MD and M. Tarek Al-Assi, MD.